Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-22-002290

Chief Financial Officer sold 40,000 shares at an average $61.70 ($2,467,941)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Myszkowski Kenneth Allen Chief Financial Officer 2022-01-05 Sale −15,908 $60.50 $962,434 488,097 D
Myszkowski Kenneth Allen Chief Financial Officer 2022-01-05 Sale −16,528 $62.00 $1,024,736 471,569 D
Myszkowski Kenneth Allen Chief Financial Officer 2022-01-05 Sale −3,778 $63.17 $238,656 467,791 D
Myszkowski Kenneth Allen Chief Financial Officer 2022-01-05 Sale −3,786 $63.95 $242,115 464,005 D
Open-market sales · 40,000 sh · avg $61.70 · $2,467,941
Loading xslF345X03/doc4.xml…